EFFECTIVENESS OF ICOSAPENT ETHYL IN MIDDLE EASTERN PATIENTS WITH DYSLIPIDEMIA

被引：0
|
作者：
Odeh, Mohamed [1 ]
Afandi, Bachar [2 ]
机构：
[1] Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia
[2] Tawam Hosp, Abu Dhabi, U Arab Emirates
来源：
ATHEROSCLEROSIS | 2024年 / 399卷
关键词：
D O I：
10.1016/j.atherosclerosis.2024.118701
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN US REDUCE-IT PATIENTS
    Weintraub, William S.
    Bhatt, Deepak
    Zhang, Zugui
    Zhang, Cheng
    Sarahfaye, Dolman
    Boden, William E.
    Steg, Philippe Gabriel
    Miller, Michael
    Brinton, Eliot
    King, Jordan
    Bress, Adam
    Jacobson, Terry
    Tardif, Jean Claude
    Ballantyne, Christie M.
    Kolm, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1914 - 1914
  • [2] Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT
    Weintraub, William S.
    Bhatt, Deepak L.
    Zhang, Zugui
    Dolman, Sarahfaye F.
    Zhang, Cheng
    Boden, William E., II
    Bress, Adam P.
    King, Jordan B.
    Steg, Philippe G.
    Brinton, Eliot A.
    Jacobson, Terry A.
    Tardif, Jean Claude
    Ballantyne, Christie M.
    Kolm, Paul
    CIRCULATION, 2019, 140 (25) : E969 - E970
  • [3] COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA
    Mistry, C.
    Tilley, L.
    Comin-Colet, J.
    Vitale, G.
    Gaugris, S.
    Jakouloff, D.
    VALUE IN HEALTH, 2024, 27 (12) : S175 - S176
  • [4] Icosapent ethyl
    Sykes, Robert
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2019, 36 (03) : 106 - +
  • [5] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PREVENTING CARDIOVASCULAR EVENTS
    Dressel, A.
    ATHEROSCLEROSIS, 2023, 379
  • [6] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PATIENTS AT HIGH CARDIOVASCULAR RISK WITH ELEVATED TRIGLYCERIDES IN GREECE
    Stratopoulos, A.
    Kougioumtzoglou, I
    Mortaki, K.
    Rigopoulos, P.
    Jakouloff, D.
    VALUE IN HEALTH, 2023, 26 (12) : S51 - S51
  • [7] Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
    Weintraub, William S.
    Bhatt, Deepak L.
    Zhang, Zugui
    Dolman, Sarahfaye
    Boden, William E.
    Bress, Adam P.
    King, Jordan B.
    Bellows, Brandon K.
    Tajeu, Gabriel S.
    Derington, Catherine G.
    Johnson, Jonathan
    Andrade, Katherine
    Steg, P. Gabriel
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Tardif, Jean-Claude
    Ballantyne, Christie M.
    Kolm, Paul
    JAMA NETWORK OPEN, 2022, 5 (02) : E2148172
  • [8] Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
    Weintraub, William S.
    Bhatt, Deepak L.
    Zhang, Zugui
    Dolman, Sarahfaye
    Boden, William E.
    Bress, Adam P.
    Bellows, Brandon K.
    Derington, Catherine G.
    Philip, Sephy
    Steg, Gabriel
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Tardif, Jean-Claude
    Ballantyne, Christie M.
    Kolm, Paul
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (01):
  • [9] Icosapent ethyl for the treatment of hypertriglyceridemia
    Ballantyne, Christie M.
    Braeckman, Rene A.
    Soni, Paresh N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1409 - 1416
  • [10] Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
    Michaeli, D. T.
    Michaeli, J. C.
    Boch, T.
    Michaeli, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2845 - 2845
12345